“showed a trend”

In the CD4 + compartment, the longitudinal model showed a trend toward statistical significance at Measurement 4 among participants who received a homologous booster ( p = 0.059). 3.9.

Children in subgroup A exhibited better H SDS during puberty and showed a trend toward higher AH SDS ( p = 0.059), suggesting that earlier initiation of therapy may be associated with improved AH outcome, in line with previous reports [ 33 , 34 ].

At this age, insoluble Aβ40 was significantly increased and insoluble Aβ42 also showed a trend of increase ( p = 0.059) in HFD-fed Irs2 −/− ;A7-Tg cortices (Fig. 6 f).

The total number of above-threshold interregional correlations in the OPR group showed a trend-level increase compared to the STA group (χ2 = 3.559, z = 1.887, p = 0.059).

In the HBS group, BMD improved more significantly in the femur (P = 0.005) and showed a trend towards improvement in the spine (P = 0.059).

In the current study, we found that DM was significantly associated with female breast cancer in the univariate analysis and showed a trend towards association ( P = 0.059) in the multivariate analysis.

11 C-deuterium-L-deprenyl PET region of interest analysis Comparisons of four groups (presymptomatic ADAD carriers, MCI PIB+, sAD and ADAD non-carriers) using Kruskal-Wallis tests in each of 11 ROIs (except for the cerebellum), showed a trend toward statistical significance for the anterior cingulate cortex, the thalamus and the hippocampus (p = 0.059–0.069) ( Supplementary Table S1b ).

The multivariate analysis, adjusted for age and lymphocytes values, showed a trend to a higher risk of adverse events in female patients compared to males ( p = 0.059) ( Figure 2 ).

The individual fluid versus neuroimaging tau biomarker models did not differ from each other (plasma p-tau217 versus tau-PET MTL , P = 0.322; plasma p-tau217 versus tau-PET NEO , P = 0.750), while the performance of tau-PET MTL showed a trend toward better performance than tau-PET NEO ( P = 0.059).

Similar data on medication overuse were unavailable from the US trial, but a secondary analysis was performed and showed a trend towards significant group differences ( P = 0.059). 56 In the European trial the responder rate of at least 50% in reduction of migraine days was significant for topiramate (22% vs 0% P = 0.012), but not in the US trial in which only the under 25% reduction in migraine/migrainous days responder rates showed significance. 57 Patients’ disability and quality of life evaluation results were different in both trials.

1 . Regression analyses, adjusted for the propensity scores to correct for the identified confounders, revealed that patients in the VKA treatment group had significantly more AsAC and DAC when compared with the non-anticoagulation group (AsAC: odds ratio [OR] 2.31, 95% confidence interval [CI] 1.16–4.59, p = 0.017; DAC: OR 2.38, 95% CI 1.22–4.67, p = 0.012) and showed a trend toward a higher calcium score of the aortic valve (AVC: OR 1.92, 95% CI 0.98–3.80, p = 0.059; Fig. 2A ).

Respondents needing additional support in environmental cleaning and disinfection were significantly more likely to request disease-specific handouts in the NICE book (88% vs 62%; χ 2 = 6.72, P = .0096) and showed a trend toward greater interest in parent letters (85% vs 67%; χ 2 = 3.55, P = .059).

Likelihood ratio testing confirmed that HER2DX metastatic score added significant prognostic information beyond ERBB2 for rwOS (χ2=10.944, p = 0.004) and showed a trend for rwPFS (χ2=5.673, p = 0.059).

After adjustment, those in the DRIFT group showed a trend towards lower odds of special school attendance in the preceding 12 months compared with those in the standard treatment group (OR 0.27 (95% CI 0.07 to 1.05), p=0.059).

Similar to the findings in all 64 patients, female patients showed a trend toward longer mPFS ( p = 0.059) and mOS ( p = 0.091).

Eukaryotic factor 2 subunit α (eIF2α Ser 51 phosphorylation showed significant interaction (p = 0.048) between fasting and insulin stimulation after the 72-hour-fast and post-hoc testing showed a trend (p = 0.059) toward decreased phosphorylation after 72 hours of fasting ( Figure 3H ).

However, patients who achieved CR before SCT showed a trend of better OS ( p = 0.059) than those with PR (Supplementary Fig. 2 ).

In our study, the MMP-1 rs1799750 1G2G genotype (compared to 2G2G) showed a trend toward increased arterial thrombosis risk (OR = 3.200, 95% CI 0.956–10.714, p = 0.059), indicating a possible association that warrants further investigation in larger cohorts.

Meta-analysis of time-domain HRV parameters showed a trend toward improvement: SDNN (g = 0.435, p = 0.059) approached significance, while RMSSD (g = 0.361, p = 0.099) and pNN50 (g = 0.222, p = 0.548) showed smaller, non-significant effects.

However, PST showed a trend of increasing FP count on the left compared with right side of the tongue, which approached significance ( p = 0.059).

In this more complex model, the main effect of APOE showed a trend (F(1,68) = 3.68, p = .059, η p 2 = .051), with higher scores for ε4 carriers compared to non-carriers, and there was also a trend for an interaction between APOE and age, with ε4 carriers scoring higher than non-carriers at younger ages and lower at older ages (F(1,68) = 3.60, p = .062, η p 2 = .050). 3.3 Discussion APOE genotype was deemed a possible predictor of individual differences since in adulthood in DS, it increases the risk of AD by a hazard ratio of 1.8 and there is evidence that the genotype also influences early brain development ( Dean et al., 2014 ; Prasher et al., 2008 ).

The linear model for peak V o 2 accounts for >50% of the observed variability and showed a trend for peak V o 2 to be lower in women ( P =0.059) and a significant decrease of peak V o 2 with advancing age ( P =0.001) and increasing WBC ( P =0.026).

Body weight showed a trend in the same direction (ρ = −0.47, p = 0.059).

Go/no-go False alarm errors in the go/no-go task showed a trend with a large effect size for a measurement time ∗ group interaction effect ( F (1,18) = 4.08, p = 0.059, η 2 = 0.185).

Interestingly, patients with initial suPAR levels above the 50 th percentile showed a trend towards an impaired postoperative outcome ( p = 0.059, Fig. 2 D).